Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
Journal:
Date of publication:
Wednesday, 1 September, 2021
Volume:
193
Issue:
Pages:
105137
EVAg connections:
Research funded by EVAg
Published by EVAg partner